Nycthemeral distribution of changes in hourly basal rate following switch to fast-acting insulin for continuous subcutaneous insulin infusion (CSII) in type 1 diabetes

被引:0
|
作者
Hermans, M
Ers, V
Buysschaert, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A106 / A106
页数:1
相关论文
共 50 条
  • [21] Reduced fear of hypoglycaemia with continuous subcutaneous insulin infusion (CSII) therapy in people with Type 1 diabetes
    Davenport, K.
    Ng, S.
    Chen, J.
    Ebsworth, T.
    Ward, C.
    Evans, M. L.
    DIABETIC MEDICINE, 2013, 30 : 147 - 147
  • [22] Use of continuous subcutaneous insulin infusion (CSII) therapy in a pediatric type 1 diabetes mellitus population
    Howard, CP
    Pettis, D
    Schurig, JM
    DIABETES, 2000, 49 : A359 - A359
  • [23] GLYCEMIC CONTROL AND PREGNANCY OUTCOME IN WOMEN WITH TYPE 1 DIABETES ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
    Cokolic, M.
    Krajnc, M.
    Zavratnik, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A51 - A52
  • [24] Defining insulin needs by means of continuous subcutaneous insulin infusion (CSII) in type I diabetes mellitus.
    Petraroli, G
    Dani, F
    Grassi, G
    Maghenzani, G
    Monge, L
    Pinach, S
    Benaduce, E
    Carta, Q
    DIABETOLOGIA, 1997, 40 : 1312 - 1312
  • [25] Type 1 diabetes patients can temporarily switch from continuous subcutaneous insulin infusion with insulin aspart to basal bolus therapy with insulin aspart and insulin glargine
    Bode, B
    Hirsch, I
    Hu, P
    Santiago, O
    DIABETES, 2003, 52 : A102 - A102
  • [26] HYBRID THERAPY IN YOUTH WITH TYPE 1 DIABETES - CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) COMBINED WITH LONG-ACTING INSULIN: A REAL-LIFE EXPERIENCE
    Lerman, L.
    Barash, G.
    Ben-Ari, T.
    Abiri, S.
    Landau, Z.
    Brener, A.
    Lebenthal, Y.
    Pinhas-Hamiel, O.
    Mazor-Aronovithch, K.
    Haim, A.
    Yeshayahu, Y.
    De Vries, L.
    Rachmiel, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A70 - A71
  • [27] BASAL AND BOLUS INSULIN REQUIREMENTS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH TYPE 1 DIABETES MELLITUS ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII): EFFECTS OF AGE AND PUBERTY
    Cemeroglu, Ayse Pinar
    Thomas, Jason P.
    Vande Zande, Luke T.
    Nguyen, Nga T.
    Wood, Michael A.
    Kleis, Lora
    Davis, Alan T.
    ENDOCRINE PRACTICE, 2013, 19 (05) : 805 - 811
  • [28] A Study of Flat and Circadian Insulin infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D)
    Rilstone, Sian K.
    Reddy, Monika
    Oliver, Nick
    DIABETES, 2019, 68
  • [29] Clinical factors influencing the basal rate profile in subjects with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pumps)
    Kahle, M.
    Buss, U.
    Varnhorn, A.
    Nawrodt, B.
    Nauck, M. A.
    DIABETOLOGIA, 2014, 57 : S53 - S53
  • [30] Insulin glulisine for continuous subcutaneous insulin infusion in pediatric type 1 diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    PEDIATRICS INTERNATIONAL, 2017, 59 (05) : 647 - 649